AstraZeneca eyes potential merger with Gilead Sciences

AstraZeneca, valued at $140 billion, is the U.K.’s biggest drugmaker by market capitalization and has developed treatments for conditions from cancer to cardiovascular disease.
https://ift.tt/eA8V8J by via Hindustan Times - business By :Buy Sports Goods From Gawin Sports At Ver Cheap Rates

Post a Comment

Previous Post Next Post